M2Care Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$30.3M
- Investors
-
8
M2Care General Information
Description
Operator of a venture studio intended to develop innovations that address major health challenges. The company tests the feasibility and viability of projects, creates and invests in healthcare startups, recruits and allocates human resources to projects, and promotes market access, helping startups secure funding and ensure they are positioned for growth and strategic acquisition.
Contact Information
Website
www.m2.careCorporate Office
- 63 Avenue Tony Garnier
- Immeuble Eklaa
- 69007 Lyon
- France
Corporate Office
- 63 Avenue Tony Garnier
- Immeuble Eklaa
- 69007 Lyon
- France
M2Care Timeline
M2Care Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 03-Sep-2025 | $30.3M | Completed | Generating Revenue | ||
| 2. Later Stage VC | 17-Dec-2024 | Completed | Generating Revenue | |||
| 1. Later Stage VC | 29-Jun-2023 | $1.35M | $1.35M | Completed | Generating Revenue |
M2Care Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
M2Care Signals
M2Care Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bpifrance | Sovereign Wealth Fund | Minority | ||
| Angel (individual) | Minority | |||
| Crédit Agricole Centre Loire | Lender/Debt Provider | Minority | ||
| Angel (individual) | Minority | |||
| Merieux Equity Partners (Lyon) | PE/Buyout | Minority |
M2Care Investments (4)
M2Care’s most recent deal was a Later Stage VC with Maculaser. The deal was made on 28-May-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Maculaser | 28-May-2026 | Later Stage VC | Diagnostic Equipment | ||
| Rhovica Neuroimaging | 18-Jul-2025 | Seed Round | Surgical Devices | ||
| TheraSonic | 14-May-2024 | Seed Round | Drug Delivery | ||
| Previa Medical | 16-Feb-2023 | Seed Round | Enterprise Systems (Healthcare) |
M2Care FAQs
-
When was M2Care founded?
M2Care was founded in 2017.
-
Where is M2Care headquartered?
M2Care is headquartered in Lyon, France.
-
What is the size of M2Care?
M2Care has 9 total employees.
-
What industry is M2Care in?
M2Care’s primary industry is Private Equity.
-
Is M2Care a private or public company?
M2Care is a Private company.
-
What is M2Care’s current revenue?
The current revenue for M2Care is .
-
How much funding has M2Care raised over time?
M2Care has raised $52.7M.
-
Who are M2Care’s investors?
Bpifrance, , Crédit Agricole Centre Loire, , and Merieux Equity Partners (Lyon) are 5 of 8 investors who have invested in M2Care.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process